Robert Whitfield MD discusses chronic inflammation and argues that conventional allopathic medicine is limited in addressing its causes. He highlights under-discussed factors such as genetics and energy medicine and describes an innovative clinical approach: using an autologous stem cell device to expand a patient’s stem cells and augment fat transfer to improve healing and pain outcomes.
There's just the reality is this happens from chronic inflammation. And then what do we need to do as providers, taking care of patients to get them to the other side of it, and what explanations need to be given, you know, for why it's happening now? I think part of it is we're pretty limited in allopathic medicine in general. We don't speak about genetics very much. It's like not taboo, but not understood. We, we certainly don't have discussions about energy medicine. We don't have discussions about different ways to optimize pain control with our patients. We just don't do those things. And I get probably a little bit of stick for that because I'm constantly trying to figure out ways to help my patients. And I really don't care how much I have to invest in my business to get her the best results. So when we do her fat transfer, if that's what she chooses, the way to optimize her result is use my new stem cell device that we can take her stem cells out, hers, expand them, and then we do her transfer, add more stem cells back, because your stem cells help you heal.
